Patterns of neuronal degeneration in the motor cortex of amyotrophic lateral sclerosis patients

1993/06/01 by Kuninobu Nihei, Ann C. McKee, Neil W. Kowall · 29 citations
Medicine · Neuroscience · #Amyotrophic Lateral Sclerosis Research #Parkinson's Disease Mechanisms and Treatments #Genetic Neurodegenerative Diseases

paper · doi:10.1007/bf00454899

Cited by

• Amyotrophic lateral sclerosis: a long preclinical period?
• Laminar fMRI in the locked-in stage of amyotrophic lateral sclerosis shows preserved activity in layer Vb of primary motor cortex
• Laminar fMRI in the locked-in stage of amyotrophic lateral sclerosis shows preserved activity in layer Vb of primary motor cortex
• Pathological TDP-43 changes in Betz cells differ from those in bulbar and spinal α-motoneurons in sporadic amyotrophic lateral sclerosis
• A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade? [europepmc]
• Functional neuroimaging at different disease stages reveals distinct phases of neuroplastic changes in amyotrophic lateral sclerosis. [europepmc]
• Axonal damage in multiple sclerosis. [europepmc]
• AAV2 mediated retrograde transduction of corticospinal motor neurons reveals initial and selective apical dendrite degeneration in ALS. [europepmc]
• Unravelling the enigma of selective vulnerability in neurodegeneration: motor neurons resistant to degeneration in ALS show distinct gene expression characteristics and decreased susceptibility to excitotoxicity. [europepmc]
• Corticostriatal connectivity and its role in disease. [europepmc]
• Extent of cortical involvement in amyotrophic lateral sclerosis--an analysis based on cortical thickness. [europepmc]
• Cortical Function in Asymptomatic Carriers and Patients With C9orf72 Amyotrophic Lateral Sclerosis. [europepmc]
• Neuropathology of Amyotrophic Lateral Sclerosis and Its Variants. [europepmc]
• Transcranial magnetic stimulation to understand pathophysiology and as potential treatment for neurodegenerative diseases. [europepmc]
• Metabolic spatial connectivity in amyotrophic lateral sclerosis as revealed by independent component analysis. [europepmc]
• Altered cortical beta-band oscillations reflect motor system degeneration in amyotrophic lateral sclerosis. [europepmc]
• Pathological TDP-43 changes in Betz cells differ from those in bulbar and spinal α-motoneurons in sporadic amyotrophic lateral sclerosis. [europepmc]
• Transcranial Magnetic Stimulation for the Assessment of Neurodegenerative Disease. [europepmc]
• Changes in the Excitability of Neocortical Neurons in a Mouse Model of Amyotrophic Lateral Sclerosis Are Not Specific to Corticospinal Neurons and Are Modulated by Advancing Disease. [europepmc]
• TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD. [europepmc]
• Patterned functional network disruption in amyotrophic lateral sclerosis. [europepmc]
• Stability of a chronic implanted brain-computer interface in late-stage amyotrophic lateral sclerosis. [europepmc]
• Human iPSC-derived astrocytes from ALS patients with mutated C9ORF72 show increased oxidative stress and neurotoxicity. [europepmc]
• Cortical hyperexcitability evolves with disease progression in ALS. [europepmc]
• Cortical Circuit Dysfunction as a Potential Driver of Amyotrophic Lateral Sclerosis. [europepmc]
• Quantitative patterns of motor cortex proteinopathy across ALS genotypes. [europepmc]
• Clinical diagnostic utility of transcranial magnetic stimulation in neurological disorders. Updated report of an IFCN committee. [europepmc]
• Neuronal STING activation in amyotrophic lateral sclerosis and frontotemporal dementia. [europepmc]
• Single-cell dissection of the human motor and prefrontal cortices in ALS and FTLD. [europepmc]